Welsh Carson Pays $1.14 Billion To Acquire U.S. Oncology, Inc.

EVEN AS THE LAST ISSUE of THE DARK REPORT was reaching clients with news of Genzyme Corp.’s offer to buy IMPATH Inc., another big oncology deal was announced. On March 22, 2004, Welsh, Carson, Anderson & Stowe announced an offer of $15.05 per share to purchase all remaining shares of U.S. Oncology, Inc. which it …

Welsh Carson Pays $1.14 Billion To Acquire U.S. Oncology, Inc. Read More »

To access this post, you must purchase The Dark Report.

Welsh Carson Pays $1.14 Billion To Acquire U.S. Oncology, Inc.

It’s another billion-dollar Wall Street bet on the future prospects in oncology services

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month